A recent study indicates that NRF2 modulates mRNA translation, particularly, the translation of EGFR, to promote pancreatic cancer survival through a reduction in cellular ROS levels which maintains activation of translational regulatory proteins [16]. This evidence concerns the gene NFE2L2 and pancreatic neoplasm.